Efficacy of a Mobile Phone App for Depression and Anxiety in College Students (VamosJuntxs)

October 21, 2024 updated by: University of Chile

Efficacy of a Mobile Phone Application for Early Intervention of Depression and Anxiety in Young College Students

The goal of this clinical trial is to evaluate the efficacy of a mobile phone application for the early intervention of depression and anxiety among young university students in Chile. The main question it aims to answer is:

- Can a mobile app reduce depressive and anxious symptomatology in college students?

Researchers will compare the intervention arm (mobile app users) to the control group (receives psychoeducational material and mental health care resources) to see if the app leads to significant improvements in depressive and anxious symptoms and well-being.

Participants will:

  • Be randomly assigned to either the intervention or control group.
  • Use the mobile application, which includes psychoeducational materials, cognitive-behavioral therapy modules, and periodic personalized feedback.
  • Complete assessments at baseline, post-intervention, and 3 and 6 months after randomization using online tools such as the PHQ-9 for depressive symptoms and the GAD-7 for anxious symptoms.

Study Overview

Status

Enrolling by invitation

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Region Metropolitana
      • Santiago, Region Metropolitana, Chile, 8380455
        • CEMERA, Faculty of Medicine, Universidad de Chile

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • PHQ-9 and GAD-7 score between 5 and 14 points
  • Have a stable internet connection
  • To provide informed consent

Exclusion Criteria:

  • High risk of suicide according to C-SSRS
  • Currently undergoing psychological, psychiatric and/or psychopharmacological treatment
  • Bipolar disorder, psychotic disorder or substance use disorder assessed with the respective modules of the MINI interview.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group

The intervention consists of an indicated prevention program delivered through a mobile app. The program will last 6 weeks and includes the following:

  1. Psychoeducation on depression and anxiety
  2. CBT skills training
  3. mood and symptom monitoring and feedback: mood tracker and the application every two weeks of the PHQ-4 and question 9 of the PHQ-9
  4. Chat with a psychologist (on demand)
  5. Optional modules on other related mental health topics (e.g. healthy habits, relaxation, mindfulness)

Additionally, participants will be able to access additional help resources that include a speed dial button for a suicide prevention hotline and a web link to access contact information for mental health services. Finally, the intervention protocol also includes the eventual referral to face-to-face mental health care if required.

Psychoeducational materials (videos, information and interactive exercises) about depression, anxiety and social support

Skills training through information and activities based on the principles of cognitive behavioral therapy (cognitive restructuring, behavioral activation, emotional regulation, problem solving and exposure)

Active Comparator: Control Group
Participants in the enhanced control group will receive a web link (https://concienciasaludable.uchile.cl/) with information about places to go to seek mental health care both inside and outside the respective university and psychoeducational material on depression and anxiety
mental health psychoeducational campaign (https://concienciasaludable.uchile.cl/)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression symptoms
Time Frame: 6-weeks post-randomization
PHQ-9, total score varies between 0 and 27, higher values represent a worse outcome
6-weeks post-randomization
Anxiety symptoms
Time Frame: 6-weeks post-randomization
GAD-7, total score varies between 0 and 21, higher values represent a worse outcome
6-weeks post-randomization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Well-being
Time Frame: 6-weeks post-randomization
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS), total score varies between 7 and 35, higher values represent a better outcome
6-weeks post-randomization
User Satisfaction
Time Frame: 6-weeks post-randomization
Ad-hoc satisfaction questionnaire for the intervention group, total score varies between 7 and 28, higher values represent a better outcome and an overall index with values ranging from 1 to 10
6-weeks post-randomization
Depression symptoms
Time Frame: 3-months post-randomization
PHQ-9, total score varies between 0 and 27, higher values represent a worse outcome
3-months post-randomization
Anxiety symptoms
Time Frame: 3-months post-randomization
GAD-7, total score varies between 0 and 21, higher values represent a worse outcome
3-months post-randomization
Well-being
Time Frame: 3-months post-randomization
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS), total score varies between 7 and 35, higher values represent a better outcome
3-months post-randomization
Depression symptoms
Time Frame: 6-months post-randomization
PHQ-9, total score varies between 0 and 27, higher values represent a worse outcome
6-months post-randomization
Anxiety symptoms
Time Frame: 6-months post-randomization
GAD-7, total score varies between 0 and 21, higher values represent a worse outcome
6-months post-randomization
Well-being
Time Frame: 6-months post-randomization
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS), total score varies between 7 and 35, higher values represent a better outcome
6-months post-randomization

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 23, 2024

Primary Completion (Estimated)

June 30, 2025

Study Completion (Estimated)

August 30, 2025

Study Registration Dates

First Submitted

October 3, 2024

First Submitted That Met QC Criteria

October 3, 2024

First Posted (Actual)

October 8, 2024

Study Record Updates

Last Update Posted (Actual)

October 23, 2024

Last Update Submitted That Met QC Criteria

October 21, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depressive Symptoms

Clinical Trials on VamosJuntxs App

Subscribe